Genetic hyperthyroidism: Hyperthyroidism due to activating TSHR mutations

European Journal of Endocrinology

Volumn 164, Issue 1, 2011, Pages 1-9

  Hebrant A ^a   Van Staveren, W C G ^a   Maenhaut, C ^a   Dumont, J E ^a   Leclere J ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE; THYROID ANTIBODY; THYROTROPIN RECEPTOR; CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; SODIUM IODIDE SYMPORTER; THYROTROPIN RECEPTOR ANTIBODY;

AUTONOMOUS ADENOMA; ENDOCRINE OPHTHALMOPATHY; FAMILIAL NONAUTOIMMUNE HYPERTHYROIDISM; GENE EXPRESSION; GENE MUTATION; GOITER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPORADIC CONGENITAL NONAUTOIMMUNE HYPERTHYROIDISM; THYROID WEIGHT; THYROIDECTOMY; THYROTOXICOSIS; ANTIBODY BLOOD LEVEL; ARTICLE; CAUSAL ATTRIBUTION; CELL COUNT; CLINICAL FEATURE; DISEASE CONTROL; DRUG SENSITIVITY; EYE DISEASE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC VARIABILITY; MOLECULAR BIOLOGY; MOLECULAR PATHOLOGY; NONHUMAN; ONSET AGE; ORGAN SIZE; SIGNAL TRANSDUCTION; THYROID ADENOMA; THYROID GLAND; TISSUE STRUCTURE;

ADENOMA; GENE EXPRESSION REGULATION; GERM-LINE MUTATION; HUMANS; HYPERTHYROIDISM; MUTATION; PHENOTYPE; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; THYROID HORMONES; THYROID NEOPLASMS;

EID: 78751555174     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0775     Document Type: Review

References (65)

1. Leclere J & Thomas JL. Diffuse nonautoimmune hyperthyroidism. Annales d'Endocrinologie 1982 43 553-568.
2. Thomas JS, Leclere J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C & Guedenet JC. Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinologica 1982 100 512-518. (doi:10.1530/acta.0. 1000512) (Pubitemid 12089226)
3. Leclere J, Bene MC, Duprez A, Faure G, Thomas JL, Vignaud JM & Burlet C. Behaviour of thyroid tissue from patients with Graves' disease in nude mice. Journal of Clinical Endocrinology and Metabolism 1984 59 175-177. (doi:10.1210/jcem-59-1-175) (Pubitemid 14087547)
4. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J & Dumont J. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genetics 1994 7 396-401. (doi:10.1038/ng0794-396)
5. Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE & Vassart G. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. New England Journal of Medicine 1995 332 150-154. (doi:10.1056/NEJM199501193320304)
6. Corvilain B, Van Sande J, Dumont JE & Vassart G. Somatic and germline mutations of the TSH receptor and thyroid diseases. Clinical Endocrinology 2001 55 143-158. (doi:10.1046/j.1365-2265.2001.01365.x)
7. Krohn K, Fuhrer D, Holzapfel HP & Paschke R. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. Journal of Clinical Endocrinology and Metabolism 1998 83 130-134. (doi:10.1210/jc.83.1.130)
8. Hebrant A, Van Sande J, Roger PP, Patey M, Klein M, Bournaud C, Savagner F, Leclere J, Dumont JE, van StaverenWC & Maenhaut C. Thyroid gene expression in familial nonautoimmune hyperthyroidism shows common characteristics with hyperfunctioning autonomous adenomas. Journal of Clinical Endocrinology and Metabolism 2009 94 2602-2609. (doi:10.1210/jc.2008-2191)
9. Gozu HI, Lublinghoff J, Bircan R & Paschke R. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism. Molecular and Cellular Endocrinology 2010 322 125-134. (doi:10.1016/j.mce.2010.02.001)
10. Leclere J, Bene MC, Aubert V, Klein M, Pascal-Vigneron V, Weryha G & Faure G. Clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia. Hormone Research 1997 47 158-162. (doi:10.1159/000185459)
11. Horton GL & Scazziga B. Hereditary hyperthyroidism with diffuse non autoimune hyperactivity due to autonomy of function and growth. Annales d'Endocrinologie 1987 48 92.
12. Watkins MG, Dejkhamron P, Huo J, Vazquez DM & Menon RK. Persistent neonatal thyrotoxicosis in a neonate secondary to a rare thyroid-stimulating hormone receptor activating mutation: case report and literature review. Endocrine Practice 2008 14 479-483.
13. de Roux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E & Misrahi M. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1996 81 2023-2026. (doi:10.1210/jc.81.6.2023)
14. Tonacchera M, Agretti P, Rosellini V, Ceccarini G, Perri A, Zampolli M, Longhi R, Larizza D, Pinchera A, Vitti P & Chiovato L. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid 2000 10 859-863. (doi:10.1089/thy.2000. 10.859)
15. Bircan R, Miehle K, Mladenova G, Ivanova R, Ivanova R, Sarafova A, Borissova AM, Lublinghoff J & Paschke R. Multiple relapses of hyperthyroidism after thyroid surgeries in a patient with long term follow-up of sporadic non-autoimmune hyperthyroidism. Experimental and Clinical Endocrinology and Diabetes 2008 116 341-346. (doi:10.1055/s-2007-1004566) (Pubitemid 351947864)
16. Chester J, Rotenstein D, Ringkananont U, Steuer G, Carlin B, Stewart L, Grasberger H & Refetoff S. Congenital neonatal hyperthyroidism caused by germline mutations in the TSH receptor gene. Journal of Pediatric Endocrinology and Metabolism 2008 21 479-486.
17. Clement S, Refetoff S, Robaye B, Dumont JE & Schurmans S. Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-Ir receptor in the thyroid gland. Endocrinology 2001 142 5131-5139. (doi:10.1210/en.142.12.5131)
18. Fuhrer D, Warner J, Sequeira M, Paschke R, Gregory J & Ludgate M. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Thyroid 2000 10 1035-1041. (doi:10.1089/thy.2000.10.1035) (Pubitemid 32095071)
19. Karges B, Krause G, Homoki J, Debatin KM, de Roux N & KargesW. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5. Journal of Endocrinology 2005 186 377-385. (doi:10.1677/joe.1.06208)
20. Supornsilchai V, Sahakitrungruang T, Wongjitrat N, Wacharasindhu S, Suphapeetiporn K & Shotelersuk V. Expanding clinical spectrum of non-autoimmune hyperthyroidism due to an activating germline mutation, p.M453T, in the thyrotropin receptor gene. Clinical Endocrinology 2009 70 623-628. (doi:10.1111/j.1365-2265.2008.03367.x)
21. Vaidya B, Campbell V, Tripp JH, Spyer G, Hattersley AT & Ellard S. Premature birth and low birth weight associated with non-autoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation. Clinical Endocrinology 2004 60 711-718. (doi:10.1111/j.1365-2265.2004.02040.x)
22. Gerding MN, Van Der Meer JW, Broenink M, Bakker O, Wiersinga WM & Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clinical Endocrinology 2000 52 267-271. (doi:10.1046/j.1365-2265.2000.00959.x)
23. Schwab KO, Gerlich M, Broecker M, Sohlemann P, Derwahl M & Lohse MJ. Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. Journal of Pediatrics 1997 131 899-904. (doi:10.1016/S0022-3476(97)70040-4)
24. Khoo DH, Parma J, Rajasoorya C, Ho SC & Vassart G. A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family. Journal of Clinical Endocrinology andMetabolism 1999 84 1459-1462. (doi:10.1210/jc.84.4.1459) (Pubitemid 30644415)
25. Ferrara AM, Capalbo D, Rossi G, Capuano S, Del Prete G, Esposito V, Montesano G, Zampella E, Fenzi G, Salerno M & Macchia PE. A new case of familial nonautoimmune hyperthyroidism caused by the M463V mutation in the TSH receptor with anticipation of the disease across generations: a possible role of iodine supplementation. Thyroid 2007 17 677-680. (doi:10.1089/thy.2006.0333)
26. Kopp P, Jameson JL & Roe TF. Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid 1997 7 765-770. (doi:10.1089/thy.1997.7.765)
27. Paschke R, Vassart G & Ludgate M. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clinical Endocrinology 1995 42 565-569. (doi:10.1111/j.1365-2265.1995.tb02681.x)
28. Kumar S, Coenen MJ, Scherer PE & Bahn RS. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 2004 89 930-935. (doi:10.1210/jc.2003- 031427)
29. Zhang L, Bowen T, Grennan-Jones F, Paddon C, Giles P, Webber J, Steadman R & Ludgate M. Thyrotropin receptor activation increases hyaluronan production in preadipocytes-fibroblasts; contribution role in hyaluronan accumulation in thyroid dysfunction. Journal of Biological Chemistry 2009 284 26447-26455. (doi:10.1074/jbc.M109.003616)
30. Liu Z, Sun Y, Dong Q, He M, Cheng CH & Fan F. A novel TSHR gene mutation (Ile691Phe) in a Chinese family causing autosomal dominant non-autoimmune hyperthyroidism. Journal of Human Genetics 2008 53 475-478. (doi:10.1007/s10038-008-0257-3)
31. Nwosu BU, Gourgiotis L, Gershengorn MC & Neumann S. A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as cause of hereditary nonautoimmune hyperthyroidism. Thyroid 2006 16 505-512. (doi:10.1089/thy.2006.16.505)
32. Vos XG, Smit N, Endert E, Tijssen JG & Wiersinga WM. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study. Clinical Endocrinology 2008 69 311-317. (doi:10.1111/j.1365-2265.2008.03192.x) (Pubitemid 352009024)
33. Pohlenz J, Pfarr N, Kruger S & Hesse V. Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R). Acta Paediatrica 2006 95 1685-1687. (doi:10.1080/08035250600774122)
34. Nishihara E, Nagayama Y, Amino N, Hishinuma A, Takano T, Yoshida H, Kubota S, Fukata S, Kuma K & Miyauchi A. A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism. Endocrine Journal 2007 54 927-934. (doi:10.1507/endocrj.K07-088)
35. sα protein gene in 31 toxic thyroid nodules. Journal of Clinical Endocrinology and Metabolism 1997 82 3885-3891. (doi:10.1210/jc.82.11.3885)
36. Akcurin S, Turkkahraman D, Tysoe C, Ellard S, De Leener A, Vassart G & Costagliola S. A family with a novel TSH receptor activating germline mutation (p.Ala485Val). European Journal of Pediatrics 2008 167 1231-1237. (doi:10.1007/s00431-007-0659-9)
37. Krohn K & Paschke R. Somatic mutations in thyroid nodular disease. Molecular Genetics and Metabolism 2002 75 202-208. (doi:10.1006/mgme.2001.3290)
38. Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J, Araujo VD, Argueso R, Barca O, Botana M, Cabezas-Agricola JM, Catalina P, Dominguez GL, Fernandez T, Mato A, Nuno A, Penin M & Victoria B. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. European Journal of Endocrinology 2008 159 623-631. (doi:10.1530/EJE-08-0313)
39. sα mutations in 45 autonomously functioning thyroid nodules in Japan. Endocrine Journal 2009 56 791-798. (doi:10.1507/endocrj.K09E-073)
40. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL & Rodd C. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281 → isoleucine) in the extracellular domain of the thyrotropin receptor. Journal of Clinical Investigation 1997 100 1634-1639. (doi:10.1172/JCI119687)
41. Deleu S, Allory Y, Radulescu A, Pirson I, Carrasco N, Corvilain B, Salmon I, Franc B, Dumont JE, Van Sande J & Maenhaut C. Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid 2000 10 131-140. (doi:10.1089/thy.2000.10.131)
42. Van Sande J, Lamy F, Lecocq R, Mirkine N, Rocmans P, Cochaux P, Mockel J & Dumont JE. Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3′,5′-monophosphate metabolism. Journal of Clinical Endocrinology and Metabolism 1988 66 570-579. (doi:10.1210/jcem-66-3- 570)
43. Ketelbant-Balasse P, Van Sande J, Neve P & Dumont JE. Time sequence of 3′,5′-cyclic AMP accumulation and ultrastructural changes in dog thyroid slices after acute stimulation by TSH. Hormone and Metabolic Research 1976 8 212-215. (doi:10.1055/s-0028-1093662)
44. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J & Vassart G. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. Journal of Clinical Endocrinology and Metabolism 1995 80 2577-2585. (doi:10.1210/jc.80.9.2577)
45. Voigt C, Holzapfel HP, Meyer S & Paschke R. Increased expression of G-protein-coupled receptor kinases 3 and 4 in hyperfunctioning thyroid nodules. Journal of Endocrinology 2004 182 173-182. (doi:10.1677/joe.0.1820173) (Pubitemid 39076913)
46. van StaverenWC, Solis DW, Delys L, Venet D, Cappello M, Andry G, Dumont JE, Libert F, Detours V & Maenhaut C. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis. PNAS 2006 103 413-418. (doi:10.1073/pnas.0507354102)
47. Arseven OK, Wilkes WP, Jameson JL & Kopp P. Substitutions of tyrosine 601 in the human thyrotropin receptor result in increase or loss of basal activation of the cyclic adenosine monophosphate pathway and disrupt coupling to Gq/11. Thyroid 2000 10 3-10. (doi:10.1089/thy.2000.10.3)
48. Biebermann H, Schoneberg T, Schulz A, Krause G, Gruters A, Schultz G & Gudermann T. A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB Journal 1998 12 1461-1471.
49. Rosenthal D. Kinetic analysis of iodine and thyroxine metabolism in "hot" thyroid nodules. Metabolism 1981 30 384-392. (doi:10.1016/0026-0495(81)90120-7)
50. Moreno-Reyes R, Tang BN, Seret A, Goldman S, Daumerie C & Corvilain B. Impaired iodide organification in autonomous thyroid nodules. Journal of Clinical Endocrinology and Metabolism 2007 92 4719-4724. (doi:10.1210/jc.2007- 0833)
51. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont JE & Vassart G. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsa genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 1997 82 2695-2701. (doi:10.1210/jc.82.8.2695)
52. Ledent C, Coppee F, Dumont JE, Vassart G & Parmentier M. Transgenic models for proliferative and hyperfunctional thyroid diseases. Experimental and Clinical Endocrinology and Diabetes 1996 104 (Supplement 3) 43-46. (doi:10.1055/s-0029-1211683)
53. Dumont JE, Lamy F, Roger P & Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiological Reviews 1992 72 667-697.
54. 11 deficiency impairs thyroid function and prevents goiter development. Journal of Clinical Investigation 2007 117 2399-2407. (doi:10.1172/JCI30380)
55. 2+ cascade mediates TSH action on thyroid hormone synthesis. Journal of Clinical Endocrinology and Metabolism 2007 92 2816-2820. (doi:10.1210/jc.2007-0366)
56. Winkler F, Kleinau G, Tarnow P, Rediger A, Grohmann L, Gaetjens I, Krause G, L'Allemand D, Gruters A, Krude H & Biebermann H. A new phenotype of nongoitrous and nonautoimmune hyperthyroidism caused by a heterozygous thyrotropin receptor mutation in transmembrane helix 6. Journal of Clinical Endocrinology and Metabolism 2010 95 3605-3610. (doi:10.1210/jc.2010-0112)
57. Van Keymeulen A, Bartek J, Dumont JE & Roger PP. Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture. Oncogene 1999 18 7351-7359. (doi:10.1038/sj.onc.1203164) (Pubitemid 30032116)
58. Mastorakos G, Mitsiades NS, Doufas AG & Koutras DA. Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 1997 7 433-439. (doi:10.1089/thy.1997.7.433)
59. Rodien P, Bremont C, Sanson ML, Parma J, Van Sande J, Costagliola S, Luton JP, Vassart G & Duprez L. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. New England Journal of Medicine 1998 339 1823-1826. (doi:10.1056/ NEJM199812173392505)
60. Corbetta C, Weber G, Cortinovis F, Calebiro D, Passoni A, Vigone MC, Beck-Peccoz P, Chiumello G & Persani L. A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH). Clinical Endocrinology 2009 71 739-745. (doi:10.1111/j.1365-2265.2009.03568.x)
61. Krohn K, Wohlgemuth S, Gerber H & Paschke R. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. Journal of Pathology 2000 192 37-42. (doi:10.1002/1096- 9896(2000)9999:9999〈::AID-PATH650〉3.0.CO;2-3)
62. Mueller S, Gozu HI, Bircan R, Jaeschke H, Eszlinger M, Lueblinghoff J, Krohn K & Paschke R. Cases of borderline in vitro constitutive thyrotropin receptor activity: how to decide whether a thyrotropin receptor mutation is constitutively active or not? Thyroid 2009 19 765-773. (doi:10.1089/thy.2009. 0006)
63. Elgadi A, Zemack H, Marcus C & Norgren S. Tissue-specific knockout of TSHr in white adipose tissue increases adipocyte size and decreases TSH-induced lipolysis. Biochemical and Biophysical Research Communications 2010 393 526-530. (doi:10.1016/j. bbrc.2010.02.042)
64. Rubin CJ, Zody MC, Eriksson J, Meadows JR, Sherwood E, Webster MT, Jiang L, Ingman M, Sharpe T, Ka S, Hallbook F, Besnier F, Carlborg O, Bed'hom B, Tixier-Boichard M, Jensen P, Siegel P, Lindblad-Toh K & Andersson L.Whole-genome resequencing reveals loci under selection during chicken domestication. Nature 2010 464 587-591. (doi:10.1038/nature08832)
65. Sun SC, Hsu PJ,Wu FJ, Li SH, Lu CH & Luo CW. Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary. Journal of Biological Chemistry 2010 285 3758-3765. (doi:10.1074/jbc.M109.066266)